Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia
Jan Moritz Middeke(Fresenius (Germany)), Friedrich Stoelzel(University Hospital Carl Gustav Carus), Christian Thiede(University Hospital Carl Gustav Carus), Michael Krämer(University Hospital Carl Gustav Carus), Sebastian Stasik, Norbert Frickhofen, Hermann Einsele(Universitätsklinikum Würzburg), Gerhard Ehninger(University Hospital Carl Gustav Carus), Markus Schaich(Rems-Murr-Klinikum), Sebastian Scholl(Jena University Hospital), Tim H. Brümmendorf(Heidelberg University), Wolfgang E. Berdel(University Hospital Münster), Björn Steffen(Goethe University Frankfurt), Christoph Röllig(University Hospital Carl Gustav Carus), Carsten Müller‐Tidow(Heidelberg University), Claudia D. Baldus(University Hospital Schleswig-Holstein), Andreas Hochhaus(Jena University Hospital), Zdeněk Ráčil(Masaryk University), Andreas Neubauer(RWTH Aachen University), Edgar Jost(Universitätsklinikum Aachen), Regina Herbst(Klinikum Chemnitz), Jiřı́ Mayer(Masaryk University), Mathias Hänel(Klinikum Chemnitz), Volker Kunzmann(University of Würzburg), Christoph Schliemann(University Hospital Münster), Andreas Burchert(Philipps University of Marburg), Ulrich Kaiser(University of Applied Sciences Landshut), Katja Sockel(Innsbruck Medical University), Uwe Platzbecker(National Center for Tumor Diseases), Stefan W. Krause(Universitätsklinikum Erlangen), Richard Noppeney(Essen University Hospital), Hubert Serve(Goethe University Frankfurt), Martin Kaufmann(Robert Bosch Hospital), Malte von Bonin(Städtisches Klinikum Dresden), Kerstin Schäfer‐Eckart(Nuremberg Hospital), Ralph Naumann(University of Siegen), Tilman Bochtler(Heidelberg University), Alwin Krämer(Heidelberg University), Johannes Schetelig(University Hospital Carl Gustav Carus)
Cited by 3
Related Papers
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k